Vanguard Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98.4M Buy
2,145,420
+8,476
+0.4% +$422K ﹤0.01% 1534
2026
Q2
$101M Buy
2,136,944
+43,951
+2% +$2.26M ﹤0.01% 1549
2026
Q1
$124M Buy
+2,092,993
New +$136M ﹤0.01% 1349

Other funds holding PBH

Vanguard Capital Management's PBH Position: Q3 2026 in Review

Vanguard Capital Management increased its Prestige Consumer Healthcare (PBH) stake by 0.4% in Q3 2026, buying an estimated $422K and bringing the position to 2,145,420 shares worth $98.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Vanguard Capital Management first reported a position in PBH in Q1 2026 and has held it in 3 quarters since. The position peaked at $124M in Q1 2026. 335 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • Vanguard Capital Management held 2,145,420 shares of Prestige Consumer Healthcare worth $98.4M as of Q3 2026.
  • Vanguard Capital Management bought 8,476 Prestige Consumer Healthcare shares in Q3 2026, an estimated $422K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1534 holding.
  • Vanguard Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Prestige Consumer Healthcare position peaked at $124M in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.